acc0301 |
AKT |
phosphorylation |
Ser473 |
human |
Sarcoma |
SYO-1 |
Dasatinib |
Unresolved |
4.0 |
23580575
|
acc0302 |
FAK |
phosphorylation |
Tyr576 |
human |
Sarcoma |
CME-1 |
Dasatinib |
Unresolved |
4.0 |
23580575
|
acc0303 |
FAK |
phosphorylation |
Tyr576 |
human |
Sarcoma |
1273/99 |
Dasatinib |
Unresolved |
4.0 |
23580575
|
acc0304 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Ovarian Cancer |
A2780/CP |
beta-Elemene + Cisplatin |
Unresolved |
4.0 |
23277286
|
acc0305 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Ovarian Cancer |
MCAS |
beta-Elemene + Cisplatin |
Unresolved |
4.0 |
23277286
|
acc0306 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Negative |
5.0 |
23319394
|
acc0307 |
p70S6K |
phosphorylation |
Thr389 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Negative |
5.0 |
23319394
|
acc0308 |
S6RP |
phosphorylation |
Ser235 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Negative |
5.0 |
23319394
|
acc0309 |
S6RP |
phosphorylation |
Ser236 |
human |
Lung Cancer |
PC9 |
Erlotinib |
Negative |
5.0 |
23319394
|
acc0310 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
PC9 |
BEZ235 |
Unresolved |
4.0 |
23319394
|
acc0311 |
p70S6K |
phosphorylation |
Thr389 |
human |
Lung Cancer |
PC9 |
BEZ235 |
Unresolved |
4.0 |
23319394
|
acc0312 |
S6RP |
phosphorylation |
Ser235 |
human |
Lung Cancer |
PC9 |
BEZ235 |
Unresolved |
4.0 |
23319394
|
acc0313 |
S6RP |
phosphorylation |
Ser236 |
human |
Lung Cancer |
PC9 |
BEZ235 |
Unresolved |
4.0 |
23319394
|
acc0314 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
BxPC3 |
Rapamycin |
Unresolved |
4.0 |
23443316
|
acc0315 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
PANC-1 |
Rapamycin |
Unresolved |
4.0 |
23443316
|
acc0316 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
HT29 |
3-deazaneplanocin A (DZNep) |
Unresolved |
4.0 |
23588203
|
acc0317 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
|
3-deazaneplanocin A (DZNep) |
Unresolved |
4.0 |
23588203
|
acc0318 |
IkappaBalpha |
phosphorylation |
Ser32 |
human |
Ovarian Cancer |
OVCAR-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0319 |
IkappaBalpha |
phosphorylation |
Ser32 |
human |
Ovarian Cancer |
SK-OV-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0320 |
IkappaBalpha |
phosphorylation |
Ser36 |
human |
Ovarian Cancer |
OVCAR-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0321 |
IkappaBalpha |
phosphorylation |
Ser36 |
human |
Ovarian Cancer |
SK-OV-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0322 |
p65 |
phosphorylation |
Ser536 |
human |
Ovarian Cancer |
OVCAR-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0323 |
p65 |
phosphorylation |
Ser536 |
human |
Ovarian Cancer |
SK-OV-3 |
Minocycline |
Unresolved |
4.0 |
23858099
|
acc0324 |
AKT |
phosphorylation |
Thr308 |
human |
Hepatocellular Carcinoma |
CSQT-2 |
all-trans retinoic acid (ATRA) + cisplatin |
Unresolved |
4.0 |
23867314
|
acc0325 |
AKT |
phosphorylation |
Thr308 |
human |
Hepatocellular Carcinoma |
HuH-7 |
all-trans retinoic acid (ATRA) + cisplatin |
Unresolved |
4.0 |
23867314
|
acc0326 |
AKT |
phosphorylation |
Ser473 |
human |
Hemangioma |
|
Rapamycin |
Unresolved |
4.0 |
23938603
|
acc0327 |
PKCalpha |
phosphorylation |
Ser657 |
human |
Hemangioma |
|
Rapamycin |
Unresolved |
4.0 |
23938603
|
acc0328 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0329 |
EGFR |
phosphorylation |
Tyr1173 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0330 |
ERK2 |
phosphorylation |
Thr185 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0331 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0332 |
AKT |
phosphorylation |
Thr308 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0333 |
AKT |
phosphorylation |
Thr308 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0334 |
ERK1 |
phosphorylation |
Thr202 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0335 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0336 |
ERK2 |
phosphorylation |
Thr185 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0337 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Thyroid Cancer |
8305C |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0338 |
ERK1 |
phosphorylation |
Thr202 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0339 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Thyroid Cancer |
FB3 |
Sunitinib |
Unresolved |
4.0 |
23969186
|
acc0340 |
GSK3b |
phosphorylation |
Ser9 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib |
Positive |
5.0 |
24113128
|
acc0341 |
GSK3b |
phosphorylation |
Ser9 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Sorafenib |
Positive |
5.0 |
24113128
|
acc0342 |
S6K |
phosphorylation |
Thr389 |
human |
Colorectal Cancer |
HT29 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0343 |
S6K |
phosphorylation |
Thr389 |
human |
Colorectal Cancer |
DLD-1 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0344 |
S6 |
phosphorylation |
Ser235 |
human |
Colorectal Cancer |
HT29 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0345 |
S6 |
phosphorylation |
Ser235 |
human |
Colorectal Cancer |
DLD-1 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0346 |
S6 |
phosphorylation |
Ser236 |
human |
Colorectal Cancer |
HT29 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0347 |
S6 |
phosphorylation |
Ser236 |
human |
Colorectal Cancer |
DLD-1 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0348 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
HT29 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0349 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
DLD-1 |
AZD2014 |
Unresolved |
4.0 |
24309100
|
acc0350 |
p27 |
phosphorylation |
Thr187 |
human |
Hepatocellular Carcinoma |
HuH-7 |
MIF4GD OV |
Unresolved |
3.0 |
24336329
|